Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions
| Status: | Completed |
|---|---|
| Conditions: | Depression |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 2/7/2018 |
| Start Date: | August 2008 |
| End Date: | September 2008 |
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Imipramine Pamoate Capsules, 75 mg, Under Fasted Conditions
The objective of this study was to prove the bioequivalence of Imipramine Pamoate 75 mg
Capsules under fasting conditions
Capsules under fasting conditions
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to imipramine pamoate or any comparable or
similar product.
We found this trial at
1
site
Click here to add this to my saved trials
